SENSORION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.706 EUR | -0.56% |
|
-1.12% | +64.19% |
| 04-08 | Sensorion: completion of a private placement | CF |
| 04-05 | Sensorion SA announced that it expects to receive ?15 million in funding | CI |
Chart calendar Sensorion
4107ac79a6ad25c19e8127a5f5.-WWw3i4NssESfJSfDWOi-LStE8KeAFMPXtZkxNMW6S0.mwyGlkV_gqt4M92qOATpouDjIKSvZRxlJ5wriLBR23eMVdaRVG7L82o7_w~41166030fe3c55d558c291df93ff29a6
Upcoming events on Sensorion
Past events on Sensorion
| 15/04/2024 | Van Lanschot Kempen Life Sciences Conference |
| 19/03/2024 13:50 | Bioprocessing Europe Summit |
| 19/03/2024 07:25 | Bioprocessing Europe Summit |
| 14/03/2024 06:30 | Q4 2023 Earnings Release |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 05/02/2024 22:30 | Association for Research in Otolaryngology Midwinter Meeting - Podium Presentation Session 13 |
| 04/02/2024 22:15 | Association for Research in Otolaryngology Midwinter Meeting - Poster Number: SU56 |
| 04/02/2024 21:15 | Association for Research in Otolaryngology Midwinter Meeting - Poster Number: SU57 |
| 03/02/2024 21:00 | Association for Research in Otolaryngology Midwinter Meeting - Poster Number: S61 |
| 03/02/2024 18:00 | Association for Research in Otolaryngology Midwinter Meeting - Symposium on OTOF Therapy Clinical Tr |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 20/12/2023 13:00 | Shareholders Meeting |
| 13/11/2023 | Jefferies London Healthcare Conference |
| 06/11/2023 | European Health And Life Sciences Symposium |
| 26/10/2023 19:30 | European Society of Gene and Cell Therapy Conference |
| 25/10/2023 16:00 | European Society of Gene and Cell Therapy Conference |
| 23/10/2023 | HealthTech Innovation Day |
| 03/10/2023 13:00 | Chardan Genetic Medicines Conference |
| 20/09/2023 06:30 | Q2 2023 Earnings Release |
| 05/07/2023 16:00 | Investor Meeting - Key Opinion Leader |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2,52 2,60 -2.97% | 2,42 3,65 -33.66% | 4,35 4,15 4.87% | 5,01 5,53 -9.54% | 5,70 4,00 42.45% | 14,6 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 0,00 - | -8,58 -9,50 9.71% | -14,7 -16,5 10.96% | -22,4 -20,3 -10.2% | 0,00 -25,8 - | -27,9 |
|
EBIT Million EUR | Released Forecast Spread | -10,8 -12,3 12.08% | -8,89 -14,9 40.34% | -15,0 -18,5 18.7% | -23,1 -21,0 -10.36% | -22,3 -25,8 13.53% | -28,3 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -12,1 -13,2 8.29% | -8,98 -11,8 23.91% | -15,1 -19,0 20.25% | -23,2 -21,4 -8.38% | 0,00 -25,6 - | -28,2 |
|
Net income Million EUR | Released Forecast Spread | -12,1 -13,2 8.36% | -8,98 -15,9 43.36% | -15,1 -19,0 20.25% | -23,2 -21,4 -8.38% | -22,1 -25,7 14.15% | -28,3 |
|
EPS EUR | Released Forecast Spread | -0,65 -0,41 -58.54% | -0,15 -0,23 34.78% | -0,19 -0,24 20.83% | -0,29 -0,27 -7.41% | 0,00 -0,19 - | -0,13 |
| Announcement Date | 02/04/20 | 18/03/21 | 28/04/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 0,90 | 1,52 1,00 51.91% | 1,60 | 2,74 1,95 40.76% | 1,90 3,10 -38.66% | 2,10 | 2,65 0,00 - | 1,36 | 2,74 | 2,96 | 3,00 | 3,00 |
|
EBITDA Million EUR | Released Forecast Spread | -15,1 | -13,6 | -12,5 | -14,6 | ||||||||
|
EBIT Million EUR | Released Forecast Spread | -4,21 -5,20 18.96% | -8,88 -10,8 17.82% | -12,2 -9,50 -28.58% | -11,2 | ||||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,26 -7,10 40.01% | -8,89 -11,6 23.33% | -12,3 -9,90 -23.88% | -11,7 | -12,3 -15,0 18.08% | -13,5 | -12,3 | -14,6 | ||||
|
Net income Million EUR | Released Forecast Spread | -4,72 | -4,26 -7,10 40.01% | -6,24 | -8,89 -11,6 23.33% | -12,3 -9,90 -23.88% | -11,7 | -12,3 -15,0 18.08% | -13,5 | -12,4 | -14,6 | ||
|
EPS EUR | Released Forecast Spread | -0,06 -0,10 40% | -0,11 -0,10 -10% | -0,15 -0,10 -50% | -0,10 | -0,08 | -0,07 | -0,07 | -0,08 | ||||
| Announcement Date | 21/10/20 | 18/03/21 | 27/09/21 | 28/04/22 | 22/09/22 | - | 20/09/23 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Sensorion
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALSEN Stock
- Calendar Sensorion
